TP53 and non-small cell lung carcinoma: We found that there was no correlation between the expression of GOLM1 and the survival rate in NSCLC patients with P53 mutation (p = 0.06252), but a significant correlation was found in NSCLC patients expressing wild-type p53 (p = 0.02449) (see Supplementary Data F).